COVID-19 in Children with Brain-Based Developmental Disabilities: A Rapid Review
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Background
The prevalence of symptomatic COVID-19 in children remains low to date. In just a few months, COVID-19 has affected millions of people worldwide, and as of the date of this publication, the pandemic continues. Based on the current available evidence, children do not appear to be at higher risk of contracting COVID-19 than adults. However, children with neurological and neuromuscular conditions are vulnerable to the respiratory complications of other viral infections.
Objectives
To assess whether children with brain-based developmental disabilities were more likely to develop COVID-19 and have complications or poorer outcomes following infection.
Methods
We conducted a two-week rapid review on studies with primary data regarding children aged between zero and 18 years old with brain-based developmental disabilities, or who were at risk of developing such disabilities, with confirmed or suspected COVID-19. We performed our literature searches on April 18, 2020.
Results
Our search strategy identified 538 individual records, of which four were included in our review. Of the 50 COVID-19 pediatric patients reported in the included studies, a total of seven children were at risk of developing brain-based disabilities. Symptoms ranged in severity. However, generally, patients were discharged or saw improvements in their symptoms by the end of the study period. No deaths were reported.
Discussion
Our study highlights a knowledge gap regarding the impact of COVID-19 in children with brain-based developmental disabilities.
Article activity feed
-
SciScore for 10.1101/2020.05.01.20088021: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources We conducted the rapid review based on the proposed methodology guide of the Cochrane Rapid Reviews Methods Group (13). Cochrane Rapid Reviewssuggested: NoneThe MEDLINE strategy was peer reviewed by another senior information specialist prior to execution using the PRESS Checklist (15). MEDLINEsuggested: (MEDLINE, RRID:SCR_002185)& Other Non-Indexed Citations, Embase Classic+Embase Embasesuggested: (EMBASE, RRID:SCR_001650), PsycINFO, Cochrane Database of Systematic Reviews and … SciScore for 10.1101/2020.05.01.20088021: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources We conducted the rapid review based on the proposed methodology guide of the Cochrane Rapid Reviews Methods Group (13). Cochrane Rapid Reviewssuggested: NoneThe MEDLINE strategy was peer reviewed by another senior information specialist prior to execution using the PRESS Checklist (15). MEDLINEsuggested: (MEDLINE, RRID:SCR_002185)& Other Non-Indexed Citations, Embase Classic+Embase Embasesuggested: (EMBASE, RRID:SCR_001650), PsycINFO, Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Trials. PsycINFOsuggested: (PsycINFO, RRID:SCR_014799)Cochrane Databasesuggested: NoneCochrane Central Register of Controlled Trialssuggested: (Cochrane Central Register of Controlled Trials, RRID:SCR_006576)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Limitations: Our rapid review has limitations. Due to our study design, screenings and data extractions were performed by single reviewers. However, we did perform pilot-testing for each review form to optimize consistency between reviewers. Further, despite our best efforts to identify all relevant studies or relevant documentation, it is possible that some were missed due to the rapid flow at which new information becomes available.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-